Moderna, Inc. (MRNA)

206.17 USD-4.23%
Gurus hold1popularity #859 of 1982
Net buying (quarter)−$1.30B0 buying · 1 selling
Market Cap$83.42B
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -7.09

Moderna, Inc. (MRNA) is not among the 30 most-held stocks of the tracked superinvestor set. Price 206.17 USD; market cap $83.42B.

Guru Ownership

Popularity rank#859 of 1,982 securities
gurus hold it1
Net activity this quarter−$1.30B

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$0.00 · 0 new buys · 0 added $1.30B · 1 reduced · 0 sold out0 net buyers · 1 net sellers
Top 5 by conviction
Baillie Gifford2.1%Reduced -37.2%
Top 5 by value
Baillie Gifford$2.20BReduced -37.2%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2018-12-312$287.2M0.8%
2019-03-312$391.6M1.0%
2019-06-302$167.0M0.3%
2019-09-302$125.7M0.2%
2019-12-312$131.8M0.2%
2020-03-312$136.4M0.1%
2020-06-301$260.7M0.2%
2020-09-301$511.2M0.3%
2020-12-311$2.54B1.4%
2021-03-311$5.94B3.3%
2021-06-303$11.77B3.2%
2021-09-304$19.89B5.8%
2021-12-312$12.71B5.6%
2022-03-313$9.06B4.9%
2022-06-305$7.38B4.0%
2022-09-306$6.07B2.4%
2022-12-317$9.50B3.7%
2023-03-317$8.43B2.4%
2023-06-306$6.57B1.8%
2023-09-305$5.27B1.5%
2023-12-315$4.93B1.2%
2024-03-314$4.91B1.2%
2024-06-304$5.30B1.4%
2024-09-303$2.92B1.0%
2024-12-314$1.63B0.4%
2025-03-312$709.6M0.3%
2025-06-301$609.6M0.5%
2025-09-301$564.3M0.4%
2025-12-312$612.8M0.3%
2026-03-311$1.02B1.0%
2026-06-301$1.28B1.2%
2026-09-301$2.20B2.1%

Price & valuation

Prev Close215.27
Open216.94
Day Range203.84 – 222.43
52 Week Range—
Volume—
Avg Volume (3M)—
Market Cap$83.42BSEC 10-Q, 10/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.792 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-7.09SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Frequently Asked Questions

Which superinvestors own MRNA?

Moderna, Inc. (MRNA) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on MRNA bullish or bearish?

MRNA is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.